Obesity Gut Health // part

In the 2025 joint advisory “Nutritional priorities to support GLP-1 therapy for obesity”, the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Societyhighlight several key challenges during GLP-1 therapy: gastrointestinal side effects, reduced calorie intake, risk of nutrient inadequacy, loss of muscle and bone mass, treatment discontinuation and weight regain. The advisory concludes that structured nutrition and lifestyle support before, during and after treatment is central to helping clinicians advance patient health.

Key elements of nutritional priorities to support GLP-1 therapy for obesity.

At Azento Health, this is where we see the need for a new generation of companion support products. Our azh-biotics® technology platform is designed to support the gut-health and nutrition-related needs emerging around Modern Obesity Treatments – with a focus on